Canadian Solar Inc. (CSIQ) Traders See Grey Skies Ahead

Canadian Solar Inc. (NASDAQ:CSIQ) has bounced back from an early morning sell-off

by Alex Eppstein

Published on Jun 29, 2015 at 10:41 AM

Canadian Solar Inc. (NASDAQ:CSIQ) is hovering near breakeven amid the broad-market sell-off, down 0.3% this morning at $29.65. This marks quite the turnaround, though, as CSIQ plunged 7.2% out of the gate due to concerns surrounding China, where the company houses most of its operations. Based on recent options activity, this bounceback is an unwelcome sight.

During the last two weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), traders have bought to open 2.63 CSIQ puts for every call. This ratio ranks a mere 4 percentage points from a 12-month high, suggesting speculators are largely bearish toward the solar stock.

Further reflecting that negativity is CSIQ's Schaeffer's put/call open interest ratio (SOIR) of 1.41, as put open interest outweighs call open interest among options with a shelf-life of three months or less. If that's not enough, this SOIR stands above 94% of comparable readings from the past year, meaning short-term traders are more put-skewed than usual.

However, not everyone is in Canadian Solar Inc.'s (NASDAQ:CSIQ) bearish camp. All of the analysts currently tracking the security rate it a "strong buy." What's more, the stock's consensus 12-month price target of $46.84 represents a nearly 58% premium to its current perch -- and in territory not explored for seven years.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.
Wall Street Roars Higher Amid Civil Unrest
Investors weighed a mixed bag of jobs data
AstraZeneca Stock Flat Despite COVID-19 Vaccine News
AstraZeneca saw a rise in capacity for its COVID-19 vaccine candidate
The Next Big Player in U.S. MJ Boom
Most pure-play marijuana stocks in the U.S. trade on the Over-the-Counter stock exchange.